SMAD7 FOR TREATMENT AND PREVENTION OF POSTERIOR CAPSULE OPACIFICATION
作者： Wang Xiao-Jing , Petrash Mark
DOI:
关键词:
摘要: Methods and compositions for the treatment prevention of posterior capsular opacification are provided. The methods include administering a therapeutically effective amount Smad7 protein construct to subject suffering from or at risk developing capsule opacification.
lens.org 参考文章(7)
Huiyao Lan, Karneng Lai, Ultrasound Microbubble Mediated Genes Delivery System ,(2007)
Dattatreyamurty Bosukonda, Peter C. Keck, Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis ,(2012)
Xiao-jing Wang, Yosef Refaeli, Qinghong Zhang, Therapeutic applications of smad7 ,(2011)
Nancy A. Noble, Wayne A. Border, Methods for treating conditions associated with the accumulation of excess extracellular matrix ,(2005)
Daniel Bedinger, Ajay J. Narasimha, Toshihiko Takeuchi, Shireen S. Khan, Amer Mirza, Antibodies Specific for TGF-Beta ,(2012)
Xiao-mei Qu, Xing-tao Zhou, Jing-yin Zhu, Ren-yuan Chu, Qi-hua Le, Jin-hui Dai, Yan Yu, Ti Wang, Inhibition of corneal fibrosis by Smad7 in rats after photorefractive keratectomy. Chinese Medical Journal. ,vol. 126, pp. 1445- 1450 ,(2013)
Suneel Gupta, Jason T. Rodier, Ajay Sharma, Elizabeth A. Giuliano, Prashant R. Sinha, Nathan P. Hesemann, Arkasubhra Ghosh, Rajiv R. Mohan, Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo PLOS ONE. ,vol. 12, pp. e0172928- ,(2017) , 10.1371/JOURNAL.PONE.0172928